インディアナ州における大腸癌の臨床試験
インディアナ州内の拠点で、大腸癌に関する27件の研究が参加者を募集しています。
インディアナ州内の都市
公式研究テキスト（英語）
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Baptist Health Floyd, New Albany
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05673148Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- Richard L. Roudebush VA Medical Center, Indianapolis
被験者募集中
65歳〜82歳 · 全性別 · 2026/10/02更新 · NCT05612347Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Reid Health, Richmond
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Family Communications After Genetic Testing
- Reid Health, Richmond
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #4, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Community Health Network, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06324357A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Indiana University, Simon Comprehensive Cancer Center, Indianapolis
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07659795Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Franciscan Health, Indianapolis
- Franciscan Health Mooresville, Mooresville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- Community Health Network, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06663319A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Franciscan Health, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06750094A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Fort Wayne Medical Oncology & Hematology, Fort Wayne
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06662786Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- IU Health North Hospital, Carmel
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT05863195A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Local Institution - 0638, Fort Wayne
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07221357Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Community Health Network, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Indiana University (IU) School of Medicine, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Community Health Network, Inc., Indianapolis
- Hematology Oncology of Indiana, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Fort Wayne
- Clinical Study Site, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Riley Hospital for Children, Indianapolis
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
- Community Health Network, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/24更新 · NCT06586515Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
- Parkview Cancer Institute, Fort Wayne
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/14更新 · NCT05014399A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Community Health Network, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
- Indiana University, Indianapolis
被験者募集中第4相
18歳以上 · 全性別 · 2026/07/07更新 · NCT06562543The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
- University Hospital Clinical Research Center, Indianapolis
- Purdue Clinical Research Center, West Lafayette
被験者募集中
45歳〜75歳 · 全性別 · 2026/05/14更新 · NCT07086833A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- Northwest Cancer Centers, Dyer
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/18更新 · NCT06244771Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Woodland Cancer Care Center, Michigan City
- Reid Health, Richmond
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Floyd, New Albany
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。